Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Intangibles (2016 - 2025)

Historic Intangibles for Ani Pharmaceuticals (ANIP) over the last 14 years, with Q3 2025 value amounting to $499.8 million.

  • Ani Pharmaceuticals' Intangibles fell 1228.59% to $499.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $499.8 million, marking a year-over-year decrease of 1228.59%. This contributed to the annual value of $541.8 million for FY2024, which is 15923.96% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Intangibles of $499.8 million as of Q3 2025, which was down 1228.59% from $520.3 million recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Intangibles ranged from a high of $569.8 million in Q3 2024 and a low of $170.1 million during Q3 2021
  • Over the past 5 years, Ani Pharmaceuticals' median Intangibles value was $499.8 million (recorded in 2025), while the average stood at $368.7 million.
  • Its Intangibles has fluctuated over the past 5 years, first surged by 19827.61% in 2022, then tumbled by 6136.99% in 2024.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Intangibles stood at $500.5 million in 2021, then tumbled by 49.72% to $251.6 million in 2022, then decreased by 16.94% to $209.0 million in 2023, then soared by 159.24% to $541.8 million in 2024, then fell by 7.75% to $499.8 million in 2025.
  • Its Intangibles was $499.8 million in Q3 2025, compared to $520.3 million in Q2 2025 and $538.5 million in Q1 2025.